MA27519A1 - Nouveau polymorphe de n-methyl-n-(3-(3-(2-thienylcarbonyl)-pyrazol-(1,5-alpha)-pyrimidin-7-yl)phenyl)acetamide et compositions et methodes associees - Google Patents

Nouveau polymorphe de n-methyl-n-(3-(3-(2-thienylcarbonyl)-pyrazol-(1,5-alpha)-pyrimidin-7-yl)phenyl)acetamide et compositions et methodes associees

Info

Publication number
MA27519A1
MA27519A1 MA28122A MA28122A MA27519A1 MA 27519 A1 MA27519 A1 MA 27519A1 MA 28122 A MA28122 A MA 28122A MA 28122 A MA28122 A MA 28122A MA 27519 A1 MA27519 A1 MA 27519A1
Authority
MA
Morocco
Prior art keywords
thienylcarbonyl
pyrazol
alpha
phenyl
methyl
Prior art date
Application number
MA28122A
Other languages
English (en)
Inventor
Scott E Zook
Donald Hettinger
Henry R Dubois Iii
Original Assignee
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurocrine Biosciences Inc filed Critical Neurocrine Biosciences Inc
Publication of MA27519A1 publication Critical patent/MA27519A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)

Abstract

La forme polymorphe III de N-méthyl-N-(3-{3-[2-thiénylcarbonyl-pyrazol-[1,5-(alpha)]-pyrimidine-7-yl}phényl)acétamide, et son utilisation comme sédatif-hypnotique, anxiolytique, anticonvulsivant et/ou myorelaxant. Des compositions et des méthodes associées, ayant rapport particulièrement au traitement de l'insomnie, sont également divulguées.
MA28122A 2002-08-26 2005-02-25 Nouveau polymorphe de n-methyl-n-(3-(3-(2-thienylcarbonyl)-pyrazol-(1,5-alpha)-pyrimidin-7-yl)phenyl)acetamide et compositions et methodes associees MA27519A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40607202P 2002-08-26 2002-08-26

Publications (1)

Publication Number Publication Date
MA27519A1 true MA27519A1 (fr) 2005-09-01

Family

ID=31946959

Family Applications (1)

Application Number Title Priority Date Filing Date
MA28122A MA27519A1 (fr) 2002-08-26 2005-02-25 Nouveau polymorphe de n-methyl-n-(3-(3-(2-thienylcarbonyl)-pyrazol-(1,5-alpha)-pyrimidin-7-yl)phenyl)acetamide et compositions et methodes associees

Country Status (31)

Country Link
US (2) US6903106B2 (fr)
EP (1) EP1532152B1 (fr)
JP (2) JP4522859B2 (fr)
KR (1) KR101063033B1 (fr)
CN (1) CN1319974C (fr)
AP (1) AP2005003220A0 (fr)
AR (1) AR044191A1 (fr)
AT (1) ATE343581T1 (fr)
AU (1) AU2003268212B2 (fr)
BR (1) BR0313695A (fr)
CA (1) CA2493359C (fr)
DE (1) DE60309332T2 (fr)
DK (1) DK1532152T3 (fr)
EA (1) EA200500421A1 (fr)
EC (1) ECSP055703A (fr)
ES (1) ES2274260T3 (fr)
HR (1) HRP20050288A2 (fr)
IL (2) IL166621A0 (fr)
IS (1) IS7769A (fr)
MA (1) MA27519A1 (fr)
MX (1) MXPA05002251A (fr)
NO (1) NO20050615L (fr)
NZ (1) NZ538027A (fr)
OA (1) OA12917A (fr)
PE (1) PE20040979A1 (fr)
PL (1) PL374436A1 (fr)
PT (1) PT1532152E (fr)
TN (1) TNSN05058A1 (fr)
TW (1) TWI288135B (fr)
WO (1) WO2004018476A1 (fr)
ZA (1) ZA200501125B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2005003220A0 (en) * 2002-08-26 2005-03-31 Neurocrine Biosciences Inc Novel polymorph of N-Methyl-N-(3-{3-[2-Thienylcarbonyl]-Pyrazol-[1,5-Alpha]-Pyrimidin-7-YI}Phenyl) Acetanide and compositions and methods related thereto.
US7429596B2 (en) * 2003-06-20 2008-09-30 The Regents Of The University Of California 1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof
TW200630368A (en) * 2004-10-18 2006-09-01 Neurocrine Biosciences Inc Hydrate of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and processes and methods related thereto
CN100528875C (zh) * 2005-02-18 2009-08-19 美德（江西）生物科技有限公司 无结晶型态的印地普隆及其制备方法
EP1956021A1 (fr) * 2006-10-11 2008-08-13 Ferrer Internacional, S.A. Procédé de préparation d'un pyrazole[1,5-a]pyrimidine en forme crystalline
EP1918290A1 (fr) * 2006-10-11 2008-05-07 Ferrer Internacional, S.A. La polymorphe B de la N-{2-fluoro-5-[3-thiophèn-2-carbonyle)-pyrazolo[1,5-a]pyrimidin-7-yl]-phènyl}-N-methyle-acetamide
CN102180879B (zh) * 2006-11-09 2013-05-01 中国人民解放军军事医学科学院放射与辐射医学研究所 一种催眠药的多晶型α的乙酸溶剂化物
CN101177427B (zh) * 2006-11-09 2011-07-20 中国人民解放军军事医学科学院放射与辐射医学研究所 一种用于催眠的化合物的多晶型α和溶剂化物,其制备方法及含该物质的组合物
AT507187B1 (de) 2008-10-23 2010-03-15 Helmut Dr Buchberger Inhalator
CN102834987B (zh) 2010-03-25 2015-04-15 矢崎总业株式会社 接头连接器和用于识别接头连接器中的汇流条图案的方法
ES2581452T3 (es) * 2010-04-16 2016-09-05 Ivoclar Vivadent Ag Vitrocerámica y vidrio de silicato de litio con óxido de metal de transición
AT510837B1 (de) 2011-07-27 2012-07-15 Helmut Dr Buchberger Inhalatorkomponente
JP5681819B2 (ja) 2011-02-11 2015-03-11 バットマーク・リミテッド 吸入器コンポーネント
CN102174048B (zh) * 2011-03-08 2014-09-17 中国人民解放军军事医学科学院放射与辐射医学研究所 一种催眠药的新多晶型β
WO2013034459A1 (fr) 2011-09-06 2013-03-14 British American Tobacco (Investments) Limited Chauffage de matériau fumable
GB201207039D0 (en) 2012-04-23 2012-06-06 British American Tobacco Co Heating smokeable material
GB2533135B (en) 2014-12-11 2020-11-11 Nicoventures Holdings Ltd Aerosol provision systems
GB201511349D0 (en) 2015-06-29 2015-08-12 Nicoventures Holdings Ltd Electronic aerosol provision systems
GB201511361D0 (en) 2015-06-29 2015-08-12 Nicoventures Holdings Ltd Electronic vapour provision system
US11924930B2 (en) 2015-08-31 2024-03-05 Nicoventures Trading Limited Article for use with apparatus for heating smokable material
US20170055584A1 (en) 2015-08-31 2017-03-02 British American Tobacco (Investments) Limited Article for use with apparatus for heating smokable material
GB2542838B (en) 2015-10-01 2022-01-12 Nicoventures Trading Ltd Aerosol provision system
US20170119046A1 (en) 2015-10-30 2017-05-04 British American Tobacco (Investments) Limited Apparatus for Heating Smokable Material
EP4706709A3 (fr) 2016-04-27 2026-05-20 Nicoventures Trading Ltd Système de fourniture d'aérosol électronique et vaporisateur associé

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6472528B1 (en) 1999-08-10 2002-10-29 Neurocrine Biosciences, Inc. Synthesis of substituted pyrazolopyrimidines
US6399621B1 (en) * 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
US6485746B1 (en) * 2000-08-25 2002-11-26 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US6384221B1 (en) * 1999-09-02 2002-05-07 Neurocrine Biosciences, Inc. Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
KR20020035585A (ko) 1999-09-02 2002-05-11 추후기재 Ｎ-메틸-Ｎ-(3-(3-[2-티에닐카보닐]-피라졸-[1,5-α]-피리미딘-7-일)페닐)아세트아미드의 다형체 및 이와 관련된조성물과 방법
JP2001177971A (ja) * 1999-12-20 2001-06-29 Auto Network Gijutsu Kenkyusho:Kk 回転接続装置
AP2005003220A0 (en) * 2002-08-26 2005-03-31 Neurocrine Biosciences Inc Novel polymorph of N-Methyl-N-(3-{3-[2-Thienylcarbonyl]-Pyrazol-[1,5-Alpha]-Pyrimidin-7-YI}Phenyl) Acetanide and compositions and methods related thereto.

Also Published As

Publication number Publication date
PE20040979A1 (es) 2005-01-07
HK1071373A1 (en) 2005-07-15
JP4522859B2 (ja) 2010-08-11
US20040116446A1 (en) 2004-06-17
EP1532152B1 (fr) 2006-10-25
BR0313695A (pt) 2005-06-21
PL374436A1 (en) 2005-10-17
EA200500421A1 (ru) 2005-08-25
DE60309332T2 (de) 2007-05-24
ECSP055703A (es) 2005-05-30
PT1532152E (pt) 2007-02-28
ES2274260T3 (es) 2007-05-16
AR044191A1 (es) 2005-09-07
WO2004018476A1 (fr) 2004-03-04
JP2005538149A (ja) 2005-12-15
CN1319974C (zh) 2007-06-06
OA12917A (en) 2006-10-13
IS7769A (is) 2005-03-23
NO20050615L (no) 2005-03-22
AU2003268212B2 (en) 2008-08-14
KR101063033B1 (ko) 2011-09-07
NZ538027A (en) 2007-08-31
CA2493359C (fr) 2009-10-27
DK1532152T3 (da) 2007-02-26
ATE343581T1 (de) 2006-11-15
HRP20050288A2 (en) 2006-10-31
TWI288135B (en) 2007-10-11
KR20050059082A (ko) 2005-06-17
CN1678614A (zh) 2005-10-05
AU2003268212A1 (en) 2004-03-11
JP2010070561A (ja) 2010-04-02
TW200406404A (en) 2004-05-01
TNSN05058A1 (en) 2007-05-14
AP2005003220A0 (en) 2005-03-31
DE60309332D1 (de) 2006-12-07
CA2493359A1 (fr) 2004-03-04
US6903106B2 (en) 2005-06-07
EP1532152A1 (fr) 2005-05-25
US7459458B2 (en) 2008-12-02
MXPA05002251A (es) 2005-06-08
IL166621A (en) 2012-02-29
ZA200501125B (en) 2006-07-26
US20050153988A1 (en) 2005-07-14
IL166621A0 (en) 2006-01-15

Similar Documents

Publication Publication Date Title
HRP20050288A2 (en) NOVEL POLYMORPH OF N-METHYL-N-(3-{3-[2-THIENYLCARBONYL]-PYRAZOL-[1,5-α]-PYRIMIDIN-7-YL}PHENIL)ACETAMIDE AND COMPOSITIONS AND METHODS RELATED THERETO
CO5611065A2 (es) Difluorometiltiazolilcarboxanilidas
CY1108703T1 (el) Αλλοστερικοι ρυθμιστες μεταβολοτροπων υποδοχεων γλουταμικου
ATE357434T1 (de) Disubstituierte thiazolylcarboxanilide und ihre verwendung als mikrobizide
MXPA04000622A (es) Pirazolilcarboxanilidas como funguicidas.
ATE301122T1 (de) Kernerweiterte perylenbisimide und ihre verwendung als fluoreszenzfarbstoffe
DK1501507T3 (da) Tetrahydropyranyl-cyclopentyl-tertrahydropyridopyrindin-modulatorer af kemokin-receptor-aktivitet
AR038563A1 (es) Composicion de ziprasidona y controles sinteticos
DK1344768T3 (da) Syntese af substituerede pyrazolopyrimidiner
MXPA05013902A (es) Pirazolopirimidinas.
MXPA03001048A (es) Polimorfos de zaleplon y metodos para la preparacion de los mismos.
TW200510422A (en) N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-sulfonamides and compositions and methods related thereto
MXPA05008525A (es) Oxatiincarboxamidas.
EA200600777A1 (ru) N-замещённые пиразолилкарбоксанилиды
DE602004010530D1 (de) Verfahren zur herstellung von phenyltetrazolderivaten
DE60336275D1 (de) Verfahren zur Herstellung von 3-(1,3-Dihydroimidazol-2-thion-1-yl)-chromanen und thiochromanen als Dopamin-beta-hydroxylase Inhibitor
ATE340175T1 (de) Imidazo(4,5-böchinolinderivate und ihre verwendung als inhibitoren der induzierbaren no- synthase
MXPA05013743A (es) Triazolopirimidnas como fungicidas.
EA200600780A1 (ru) Гексилкарбоксанилиды и их применение для борьбы с нежелательными микроорганизмами
WO2004112480A3 (fr) Triazolopyrimidines
ATE381567T1 (de) Pyrazolopyrimidine
DK1675851T3 (da) Fremgangsmåde til fremstilling af N-substituerede 3beta-aminonortropaner